Somatic mRNA Turnover Mutants Implicate Tristetraprolin in the Interleukin-3 mRNA Degradation Pathway

REFERENCES

• Beelman, C. A., and Parker, R.. 1995. Degradation of mRNA in eukaryotes. Cell 81:179–183
   PubMed Web of Science ®Google Scholar
• Blochlinger, K., and Diggelmann, H.. 1984. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol. 4:2929–2931
   PubMed Web of Science ®Google Scholar
• Brewer, G.. 1991. An A+U-rich element RNA-binding factor regulates c-myc stability in vitro. Mol. Cell. Biol. 11:2460–2466
   PubMed Web of Science ®Google Scholar
• Brewer, G., and Ross, J.. 1989. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9:1996–2006
   PubMed Web of Science ®Google Scholar
• Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A.. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670–1674
   PubMed Web of Science ®Google Scholar
• Carballo, E., Lai, W. S., and Blackshear, P. J.. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001–1005
   PubMed Web of Science ®Google Scholar
• Chen, C.-Y. A., and Shyu, A.-B.. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465–470
   PubMed Web of Science ®Google Scholar
• Diamantis, I. D., Nair, A. P., Hirsch, H. H., and Moroni, C.. 1989. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells. Proc. Natl. Acad. Sci. USA 86:9299–9303
   PubMed Web of Science ®Google Scholar
• Engeland, K., Andrews, N. C., and Mathey-Prevot, B.. 1995. Multiple proteins interact with the nuclear inhibitory protein repressor element in the human interleukin-3 promoter. J. Biol. Chem. 270:24572–24579
   PubMed Web of Science ®Google Scholar
• Erb, P., Troxler, M., Fluri, M., Grogg, D., and Alkan, S. S.. 1991. Functional heterogeneity of CD4-positive T-cell subsets: the correlation between effector functions and lymphokine secretion is limited. Cell. Immunol. 135:232–244
   PubMedGoogle Scholar
• Fan, X. C., and Steitz, J. A.. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448–3460
   PubMed Web of Science ®Google Scholar
• Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., and Linehan, W. M.. 1996. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93:10589–10594
   PubMed Web of Science ®Google Scholar
• Gough, N. M.. 1988. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal. Biochem. 173:93–95
   PubMed Web of Science ®Google Scholar
• Hirsch, H. H., Nair, A. P., Backenstoss, V., and Moroni, C.. 1995. Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements. J. Biol. Chem. 270:20629–20635
   PubMed Web of Science ®Google Scholar
• Hirsch, H. H., Nair, A. P., and Moroni, C.. 1993. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene. J. Exp. Med. 178:403–411
   PubMed Web of Science ®Google Scholar
• Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G.Jr., and Goldberg, M. A.. 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93:10595–10599
   PubMed Web of Science ®Google Scholar
• Jacobson, A., and Peltz, S. W.. 1996. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu. Rev. Biochem. 65:693–739
   PubMed Web of Science ®Google Scholar
• John, J., McKendry, R., Pellegrini, S., Flavell, D., Kerr, I. M., and Stark, G. R.. 1991. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol. Cell. Biol. 11:4189–4195
   PubMed Web of Science ®Google Scholar
• Jones, T. R., and Cole, M. D.. 1987. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513–4521
   PubMed Web of Science ®Google Scholar
• Lai, W. S., Carballo, E., Strum, J. R., Kennington, E. A., Phillips, R. S., and Blackshear, P. J.. 1999. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 19:4311–4323
   PubMed Web of Science ®Google Scholar
• Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L. et al. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320
   PubMed Web of Science ®Google Scholar
• Levy, N. S., Chung, S., Furneaux, H., and Levy, A. P.. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:6417–6423
   PubMed Web of Science ®Google Scholar
• Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., and Krek, W.. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13:1822–1833
   PubMed Web of Science ®Google Scholar
• Loflin, P., Chen, C. Y., and Shyu, A. B.. 1999. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13:1884–1897
   PubMed Web of Science ®Google Scholar
• Ma, Q., and Herschman, H. R.. 1991. A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene 6:1277–1278
   PubMedGoogle Scholar
• Ma, W.-J., Cheng, S., Campbell, C., Wright, A., and Furneaux, H.. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144–8151
   PubMed Web of Science ®Google Scholar
• Mathey-Prevot, B., Andrews, N. C., Murphy, H. S., Kreissman, S. G., and Nathan, D. G.. 1990. Positive and negative elements regulate human interleukin 3 expression. Proc. Natl. Acad. Sci. USA 87:5046–5050
   PubMed Web of Science ®Google Scholar
• McKendry, R., John, J., Flavell, D., Muller, M., Kerr, I. M., and Stark, G. R.. 1991. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. USA 88:11455–11459
   PubMed Web of Science ®Google Scholar
• Ming, X. F., Kaiser, M., and Moroni, C.. 1998. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 17:6039–6048
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and Land, H.. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596
   PubMed Web of Science ®Google Scholar
• Myer, V. E., Fan, X. C., and Steitz, J. A.. 1997. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16:2130–2139
   PubMed Web of Science ®Google Scholar
• Nair, A. P., Diamantis, I. D., Conscience, J. F., Kindler, V., Hofer, P., and Moroni, C.. 1989. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production. Mol. Cell. Biol. 9:1183–1190
   PubMed Web of Science ®Google Scholar
• Nair, A. P., Hahn, S., Banholzer, R., Hirsch, H. H., and Moroni, C.. 1994. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 369:239–242
   PubMed Web of Science ®Google Scholar
• Nair, A. P., Hirsch, H. H., and Moroni, C.. 1992. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity. Oncogene 7:1963–1972
   PubMed Web of Science ®Google Scholar
• Pellegrini, S., John, J., Shearer, M., Kerr, I. M., and Stark, G. R.. 1989. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:4605–4612
   PubMedGoogle Scholar
• Peng, S. S., Chen, C. Y., Xu, N., and Shyu, A. B.. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:3461–3470
   PubMed Web of Science ®Google Scholar
• Ross, J.. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423–450
   PubMedGoogle Scholar
• Schuler, G. D., and Cole, M. D.. 1988. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55:1115–1122
   PubMed Web of Science ®Google Scholar
• Shaw, G., and Kamen, R.. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667
   PubMed Web of Science ®Google Scholar
• Shyu, A.-B., Greenberg, M. E., and Belasco, J. G.. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:60–72
   PubMed Web of Science ®Google Scholar
• Stoecklin, G., Hahn, S., and Moroni, C.. 1994. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269:28591–28597
   PubMed Web of Science ®Google Scholar
• Taylor, D. S., Laubach, J. P., Nathan, D. G., and Mathey-Prevot, B.. 1996. Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3. J. Biol. Chem. 271:14020–14027
   PubMedGoogle Scholar
• Taylor, G. A., Carballo, E., Lee, D. M., Lai, W. S., Thompson, M. J., Patel, D. D., Schenkman, D. I., Gilkeson, G. S., Broxmeyer, H. E., Haynes, B. F., and Blackshear, P. J.. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445–454
   PubMed Web of Science ®Google Scholar
• Taylor, G. A., Thompson, M. J., Lai, W. S., and Blackshear, P. J.. 1995. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J. Biol. Chem. 270:13341–13347
   PubMed Web of Science ®Google Scholar
• Varnum, B. C., Lim, R. W., Sukhatme, V. P., and Herschman, H. R.. 1989. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 4:119–120
   PubMed Web of Science ®Google Scholar
• Wellington, C. L., Greenberg, M. E., and Belasco, J. G.. 1993. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol. Cell. Biol. 13:5034–5042
   PubMedGoogle Scholar
• Wisdom, R., and Lee, R.. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232–243
   PubMed Web of Science ®Google Scholar
• Wyss, A., and Moroni C.. Calcium-dependent and oncogenic IL-3 mRNA stabilization can be distinguished pharmacologically and by sequence requirements in the 3′ UTR. Growth Factors, in press.
   Google Scholar
• Zhang, W., Wagner, B. J., Ehrenman, K., Schaefer, A. W., DeMaria, C. T., Crater, D., DeHaven, K., Long, L., and Brewer, G.. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652–7665
   PubMed Web of Science ®Google Scholar